Product Code: GVR-3-68038-912-8
Artificial Urinary Sphincter Market Growth & Trends:
The global artificial urinary sphincter market size is expected to reach USD 853.30 million by 2030, expanding at a CAGR of 7.1% from 2023 to 2030, based on a new report by Grand View Research, Inc.. Stress urinary incontinence (SUI) is the most prevalent form of urinary incontinence among women. According to the National Association for Incontinence, SUI affects an estimated 15 million adult women in the U.S. Furthermore, certain neurological conditions, such as multiple sclerosis, Parkinson's disease, or spinal cord injuries, can affect the nerves that control bladder function. When these nerves are damaged or impaired, it can lead to SUI. Thus, an increasing number of women patients suffering from SUI is projected to fuel demand for AUS during the forecast period.
Market players adopt various strategies to increase the reach of their products and improve availability in diverse geographic areas. In July 2023, UroMems announced that it had completed the first-ever implant of the "UroActive Smart" automated AUS in a female patient with SUI. This device is powered by a MyoElectroMechanical System (MEMS). Thus, introducing a technologically advanced AUS is expected to boost market growth. Moreover, major players are undertaking various initiatives, such as mergers & acquisitions of small firms, to strengthen their product portfolio. For instance, in August 2020, Creo Medical Group acquired Albyn Medical, a manufacturer of urology, endoscopy, and gastroenterology products, for USD 27.43. This acquisition improved Creo Medical's extensive worldwide sales, logistics, service, production, and export capability, driving the market growth.
Artificial Urinary Sphincter Market Report Highlights:
- In 2022, the AMS 800 segment dominated the market with a market share of 85.25%. This dominance can be attributed to the growing use of the device to prevent urine incontinence
- In 2022, the male segment dominated the market with a share of 87.56% due to increased awareness about the importance of AUS in preventing urinary leakages
- North America held the largest revenue share of 42.81% in 2022 due to technological advancements and high investment by the government to support the adoption of advanced AUS devices
- The global market is highly competitive and is characterized by the presence of several global as well as regional companies
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Brand
- 1.1.2. End users
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline.
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Modality outlook
- 2.2.2. Brand outlook
- 2.2.3. End Users outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Artificial Urinary Sphincter Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of urinary incontinence
- 3.2.1.2. Increasing healthcare expenditure in developing countries
- 3.2.1.3. Technological advancement
- 3.2.2. Market restraint analysis
- 3.2.2.1. Shortage of skilled health care professionals
- 3.2.2.2. Stringent government regulations
- 3.3. Artificial Urinary Sphincter Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.3. Covid-19 Impact Analysis
Chapter 4. Artificial Urinary Sphincter Market: Brand Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. AMS 800
- 4.1.2. Others
- 4.2. Brand Market Share, 2018 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Artificial Urinary Sphincter Market by Brand Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
- 4.5.1. AMS 800
- 4.5.1.1. AMS 800 market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Others
- 4.5.2.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Artificial Urinary Sphincter: End-user Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Male
- 5.1.2. Female
- 5.2. End Users Market Share, 2018 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Artificial Urinary Sphincter Market by End-user Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Male
- 5.5.1.1. Male market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Female
- 5.5.2.1. Female market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Artificial Urinary Sphincter Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2018 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Global Regional Market Snapshot
- 6.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030:
- 6.5. North America
- 6.5.1. U.S.
- 6.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.2. Canada
- 6.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6. Europe
- 6.6.1. UK
- 6.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.2. Germany
- 6.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.3. France
- 6.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.4. Italy
- 6.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.5. Spain
- 6.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.6. Norway
- 6.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.7. Sweden
- 6.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.8. Denmark
- 6.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7. Asia Pacific
- 6.7.1. Japan
- 6.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.2. China
- 6.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.3. India
- 6.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.4. Australia
- 6.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.5. South Korea
- 6.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.6. Thailand
- 6.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8. Latin America
- 6.8.1. Brazil
- 6.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.2. Mexico
- 6.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 6.8.3. Argentina
- 6.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9. MEA
- 6.9.1. South Africa
- 6.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9.2. Saudi Arabia
- 6.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9.3. UAE
- 6.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 6.9.4. Kuwait
- 6.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2022
- 7.3.4. Boston Scientific Corporation
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Creo Medical Ltd.
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Zephyr Surgical Implant.
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Rules-Based Medicine.
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. GT Urological (GTU)
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives